Biotech

All Articles

Aligos proclaims phase 2 MASH win, slashing liver fat approximately 46%

.Aligos Therapies is heralding a midstage win in metabolic-dysfunction linked steatohepatitis (MASH)...

Basilea scores $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building brand new antifungals has actually obtained a notable boost f...

Capricor sells Europe legal rights to late-stage DMD treatment for $35M

.Having already gathered up the united state civil rights to Capricor Therapeutics' late-stage Duche...

FDA junks adcomm for Applied's rare ailment drug

.After dismissing the choice meeting for Applied Rehabs' metabolic ailment medicine govorestat, the ...

Novo inks $600M NanoVation package to research genetic medicines ex-liver

.Novo Nordisk is proceeding its press into genetic medicines, consenting to pay NanoVation Therapies...

Innovent hyperlinks cytokine to colon cancer cells reactions

.Innovent Biologics has actually made the case that its own checkpoint inhibitor-cytokine combinatio...

Merck, Daiichi ADC strikes objective in stage 3 bronchi cancer research study

.A phase 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina deepens AI concentrate with collab to pick cancer intendeds

.Five months after Rakovina Rehabs rotated towards expert system, the cancer-focused biotech has joi...

Ascendis' dwarfism medicine favorites in period 3, endangers BioMarin

.Ascendis Pharma has actually become a possible danger to BioMarin's Voxzogo, stating phase 3 develo...

Despite ph. 3 miss, Alkeus views course ahead for eye disease resource

.Though Alkeus Pharmaceuticals' dental eye illness possession stopped working to dramatically decrea...